Welcome : Guest

Seres Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Seres Therapeutics, Inc., which is principally involved in providing Microbiome Therapeutics. Illustrated with 43 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-66315
Price: $2150
Company Type: Public
Pages: 44
Date: January 2017
Market Data Tables: 43

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Inflammatory Bowel Disease (IBD)......2
Table 1: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......2
Haematopoietic Stem Cell Transplantation (HSCT)......3
Table 2: Haematopoietic Stem Cell Transplantation (HSCT) Market by Region Worldwide (2015) - Percentage Share Breakdown by Volume for European Union, United States and Rest of World......3
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)......4
Table 3: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Leukemias by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......4
Table 4: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Acute Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......5
Table 5: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Chronic Leukemia by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......6
Table 6: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......7
Table 7: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoproliferative by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......8
Table 8: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Lymphoma by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......9
Table 9: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Plasma Cell Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......10
Table 10: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Non-Malignant Disorders by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......11
Table 11: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Bone Marrow Failure by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......12
Table 12: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Solid Tumors by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Americas, Europe and Others......13
Table 13: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Americas (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Chronic Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS) and Others......14
Table 14: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Market by Category in Europe (2015) - Percentage Share Breakdown by Value for Acute Leukemia, Leukemias, Lymphoma, Lymphoproliferative, Mixed Myelodysplastic and Myeloproliferative Syndromes (MDS/MPS), Non-Malignant Disorders and Others......15
Diabetes......16
Table 15: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......16
Table 16: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type 1 Diabetes, Insulin Type 2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......17
Table 17: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......18
Table 18: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......19
Table 19: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......20
Table 20: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......21
Table 21: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......22
Table 22: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......23
Table 23: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......24
Table 24: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......25
Diabetes Drugs......26
Table 25: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......26
Table 26: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......27
Table 27: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......28
Table 28: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......29
Table 29: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......30
Table 30: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......31
Table 31: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......32
Table 32: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......33
Table 33: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......34
Table 34: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......35
Table 35: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......36
Non-Insulin Anti-Diabetic Drugs......37
Table 36: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......37
Diabetic Macular Edema (DME)......38
Table 37: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......38
Table 38: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......39
Nausea and Vomiting Associated With Cancer Chemotherapy......40
Table 39: Nausea and Vomiting Associated With Cancer Chemotherapy Market by Drug in European Union (2015) - Percentage Share Breakdown by Value for Aprepitant (Emend), Netupitant (Akynzeo), and Rolapitant (Varubi)......40
Clostridium Difficile-Associated Diarrhea (CDAD)......41
Table 40: Market Shares of Leading Drugs for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in the US (2015) - Percentage Share Breakdown by Value for METRONIDAZOLE INJECTION, METRONIDAZOLE Oral, VANCOMYCIN Oral Solution and Others......41
Diabetes Drugs......42
Table 41: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......42
Table 42: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......43
Table 43: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......44